Dr. Jim Brugarolas, Director of the UT Southwestern Kidney Cancer Program, sat down with expert urologist, Dr. Vitaly Margulis, and leading oncologist, Dr. Hans Hammers, in a roundtable discussion about the CARMENA trial, a clinical trial evaluating the role of surgery for the primary tumor in the kidney in patients with metastatic disease.